Please wait...


Generic Name: riluzole (RIL yoo zol)
Brand Name: Rilutek, Tiglutik
Physician reviewed Tiglutik patient information - includes Tiglutik description, dosage and directions.
  • Prescription Settings

Prices and coupons of Tiglutik

Current Location: 20149 (Ashburn)
Change Location?

Enter your zip code

Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Tiglutik is used to treat amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. Tiglutik is not a cure for ALS, but it may delay progression of the disease and prolong your life. Tiglutik may also be used for purposes not listed in this medication guide. Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use. You should not use Tiglutik if you are allergic to it. Tiglutik is not approved for use by anyone younger than 18 years old. Learn more

Tiglutik Side Effects

Tiglutik Side Effects

Note: This document contains side effect information about riluzole. Some of the dosage forms listed on this page may not apply to the brand name Tiglutik.

For the Consumer

Applies to riluzole: oral suspension, oral tablet

Along with its needed effects, riluzole (the active ingredient contained in Tiglutik) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking riluzole:

Less common

  • Bladder pain
  • bloody or cloudy urine
  • blurred vision
  • chills
  • cough
  • dark urine
  • diarrhea
  • difficult, burning, or painful urination
  • fast, pounding, or irregular heartbeat or pulse
  • fever
  • frequent urge to urinate
  • general feeling of discomfort or illness
  • headache
  • increased cough
  • itching skin
  • joint pain
  • loss of appetite
  • lower back or side pain
  • muscle aches and pains
  • nausea
  • nervousness
  • persistent loss of appetite or weight loss
  • pounding in the ears
  • right upper quadrant tenderness
  • runny nose
  • shivering
  • slow heartbeat
  • sore throat
  • trouble sleeping
  • unusual tiredness or weakness
  • vomiting
  • yellow eyes or skin

Incidence not known

  • Black, tarry, stools
  • decreased frequency or amount of urine
  • difficult breathing
  • increased thirst
  • nausea
  • pale skin
  • swelling of the face, fingers, or lower legs
  • ulcers, sores, or white spots in the mouth
  • unusual bleeding or bruising
  • weight gain

Some side effects of riluzole may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Lack or loss of strength

Less common

  • Difficulty moving
  • dizziness or lightheadedness
  • dry mouth
  • excess air or gas in the stomach or bowels
  • feeling of constant movement of self or surroundings
  • full feeling
  • muscle stiffness
  • passing gas
  • rapid weight gain
  • sensation of spinning
  • skin rash, encrusted, scaly and oozing
  • sleepiness or unusual drowsiness
  • stomach pain
  • tingling of the hands or feet
  • unusual weight gain or loss

For Healthcare Professionals

Applies to riluzole: oral suspension, oral tablet


The most commonly reported adverse reactions have included asthenia, nausea, dizziness, decreased lung function, and abdominal pain.


In clinical trials, ALT elevations above 5 times the upper limit of normal (5 X ULN) were reported in 2% of patients, about 50% had at least 1 elevated ALT, and 8% had at least one elevated ALT level above 3 x ULN. Drug-induced hepatic injury, including fatalities, have been reported.

Study data indicate that Asian patients may be more susceptible to liver function test abnormalities; 3.2% (194/5995) of Asian patients and 1.8% (100/5641) of Caucasian patients experienced liver function test abnormalities.

Very common (10% or more): At least 1 ALT elevation of above upper limit of normal (ULN)

Common (1% to 10%): ALT elevation above 5 x ULN

Rare (0.01% to 0.1%): Hepatitis, jaundice, hepatocellular damage

Frequency not reported: Drug-induced hepatic injury

Postmarketing reports: Acute hepatitis and icteric toxic hepatitis


Uncommon (0.1% to 1%): Anemia

Rare (0.01% to 0.1%): Erythropenia, leucopenia, thrombocytopenia

Very rare (less than 0.01%): Neutropenia

There have been 3 reports (n=5000) of marked neutropenia where absolute neutrophil count was less than 500/mm3, all within first 2 months of treatment. In one case, neutrophil counts rose on continued treatment. In a second case, counts rose after therapy was stopped. A third case was associated with marked anemia with uncertain etiology


Common (1% to 10%): Decreased lung function, increased cough,

Uncommon (0.1% to 1%): Respiratory failure, interstitial lung disease

Rare (0.01% to 0.1%): Asphyxia, respiratory distress.

Frequency not reported: Hypersensitivity pneumonitis


Very common (10% or more): Nausea (16%)

Common (1% to 10%): Abdominal pain, vomiting, dry mouth, flatulence

Uncommon (0.1% to 1%): Pancreatitis

Rare (0.01% to 0.1%): Gastrointestinal disorder, gastric ulcer, gastrointestinal hemorrhage, gastrointestinal irritation, melena

Nervous system

Common (1% to 10%): Dizziness, circumoral paresthesia, somnolence

In clinical trials, the incidence of dizziness was greater in females than males (11% vs 4%). There was no difference in rates of adverse reactions leading to discontinuation between genders.


Very rare (less than 0.01%): Angioedema

Frequency not reported: Anaphylaxis


Common (1% to 10%): Insomnia

Rare (0.01% to 0.1%): Completed suicide, confusion, delirium, hallucination, personality change due to a general medical condition

Very rare (less than 0.01%): Amnesia


Postmarketing reports: Renal tubular impairment


Common (1% to 10%): Arthralgia


Common (1% to 10%): Hypertension, tachycardia, peripheral edema

Rare (0.01% to 0.1%): Angina unstable, atrial fibrillation, cardiac failure

Very rare (less than 0.01%): Arrhythmia


Rare (0.01% to 0.1%): Dehydration

Very rare (less than 0.01%): Hyponatremia


Very common (10% or more): Asthenia (19%)

Common (1% to 10%): Vertigo, malaise, pyrexia


Common (1% to 10%): Pruritus, eczema

Rare (0.01% to 0.1%): Dermatitis


Common (1% to 10%): Urinary tract infection

Editorial References and Review

Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.

Source: Drugs.com Tiglutik